Monalysin was recently described as a novel pore-forming toxin (PFT) secreted by the Drosophila pathogen Pseudomonas entomophila. Recombinant monalysin is multimeric in solution, whereas PFTs are supposed to be monomeric until target membrane association. Monalysin crystals were obtained by the hanging-drop vapour-diffusion method using PEG 8000 as precipitant. Preliminary X-ray diffraction analysis revealed that monalysin crystals belonged to the monoclinic space group C2, with unit-cell parameters a = 162.4, b = 146.2, c = 144.4 Å , = 122.8
Introduction
Pore-forming toxins (PFTs) represent the largest class of bacterial protein toxins and are often important virulence factors of a pathogen (Iacovache et al., 2010) . These proteins are initially produced as soluble molecules. Association with a target membrane, generally via specific receptors, induces their oligomerization in a ring-like structure. Subsequent structural rearrangements of each protomer generate an amphipathic surface large enough to drive spontaneous membrane insertion, leading to the formation of a water-filled pore. Depending on the PFT, pore formation is aimed at permeabilizing the target membrane or can serve as a translocation channel to introduce other virulence factors into the target cell.
PFTs can be divided into two major classes according to the secondary structure of the membrane-spanning region: -barrel (-PFT) and -helical (-PFT). Monalysin was recently identified as a new virulence factor secreted by the Drosophila pathogen Pseudomonas entomophila (Opota et al., 2011) . Genetic studies suggested that this protein is involved in the ability of the pathogen to induce intestinal cell damage in the host gut. We previously produced recombinant monalysin from Escherichia coli culture and the various studies that we carried out (sequence alignment, circular dichroism, cytotoxicity assays and planar lipid bilayer experiments) indicated that monalysin is a -PFT. Furthermore, multi-angle light-scattering analysis and electron-microscopy studies suggested that in solution monalysin is a multimeric protein with a ring-like conformation. This is in contradiction with what has been observed for all other PFTs studied until now. Indeed, the oligomerization of PFTs and subsequent organization in a ring-like structure are supposed to be induced by association with the target membrane. The structures of several PFTs have been determined, but the structures of both the soluble and the pore forms are available for only a few: the -PFT ClyA (Wallace et al., 2000; Mueller et al., 2009 ) and the -PFTs cytolysin (Olson & Gouaux, 2005; De & Olson, 2011) and -haemolysin (Olson et al., 1999; Roblin et al., 2008; Yamashita et al., 2011) . Nevertheless, the molecular mechanisms involved in the soluble-to-transmembrane-form transition of PFTs are still unknown.
Here, we present the crystallization and preliminary X-ray analysis of recombinant monalysin.
Experimental procedures

Protein expression and purification
The cloning and production of monalysin were performed as described previously (Opota et al., 2011) . Briefly, monalysin (residues 1-271) was cloned into pETG-20A vector to generate a construct encoding monalysin with an N-terminal fusion composed of the thioredoxin (TRX) protein followed by a 6ÂHis tag and a Tobacco etch virus (TEV) protease cleavage site. TEV cleavage is used to liberate the fusion, leaving an extra serine residue at the monalysin N-terminus. Monalysin was expressed in Rosetta (DE3) pLysS E. coli cells (Novagen). After cell lysis, the protein was purified from the soluble fraction by nickel-affinity chromatography and was desalted to eliminate imidazole. After an overnight incubation at 277 K with 1:20(w:w) 6ÂHis-TEV protease, monalysin was collected from the flowthrough of a second nickel purification and further purified by size-exclusion chromatography in 10 mM Tris pH 8, 500 mM NaCl. For crystallization trials, the purified monalysin was concentrated to 6.5 mg ml À1 by centrifugation using an Amicon 30 kDa cutoff concentrator in the same buffer as was used for size-exclusion chromatography. The protein concentration was determined from the absorbance at 280 nm using a NanoDrop 2000 (Thermo Scientific).
Crystallization and data collection
Initial crystallization trials were performed by the sitting-drop vapour-diffusion method at 293 K in 96-well Greiner plates with the Wizard I and II (Emerald BioSystems), PEGs Suite (Qiagen) and Crystal Screen and Crystal Screen 2 (Hampton Research) screens using a Cartesian HoneyBee robot (Genomic Solutions). Drops were prepared by mixing different volumes (100, 200 and 300 nl) of protein solution and 100 nl precipitant solution and were equilibrated against a 150 ml reservoir volume. Crystallization hits occurred in several conditions, especially Wizard I condition No. 7 [0.1 M MES pH 6.0, 0.2 M zinc acetate, 10%(w/v) PEG 8000]. After optimization, the final crystallization conditions were 0.1 M sodium acetate pH 4.6, 0.13 M zinc acetate, 0.6-1.1 M ammonium acetate, 2-7%(w/v) PEG 8000, with a protein:precipitant ratio of 3:1(v:v) in 1.5 ml hanging drops. Crystals appeared within a few days and were briefly soaked in crystallization solution supplemented with 20%(v/v) glycerol before being flash-cooled in a nitrogen-gas stream at 100 K. Native monalysin X-ray diffraction data (180 images with 1 Á', 5 s exposure and a crystal-to-detector distance of 306.42 mm) were collected to 2.85 Å resolution on beamline ID23-2 at the European Synchrotron Research Facility (ESRF), Grenoble, France using a MAR225 detector. A heavy-atom derivative search was carried out by soaking crystals for different times in a solution containing 1-50 mM of various heavy atoms. Successful derivatization was achieved by soaking native monalysin crystals in 1 mM hexatantalum tetradecabromide (Ta 6 Br 14 cluster; Knä blein et al., 1997) for 2-5 d. The crystals were backsoaked for a few minutes in crystallization solution supplemented with 20%(v/v) glycerol before being flash-cooled in a nitrogen-gas stream at 100 K. Ta 6 Br 14 cluster derivative X-ray diffraction data (480 images with 0.75 Á', 1 s exposure and a crystal-to-detector distance of 345.14 mm) were collected to 3.6 Å resolution at the tantalum peak wavelength on beamline ID23-1 at the ESRF using an ADSC Quantum Q315r detector.
X-ray crystallographic analysis
The data sets were integrated with XDS (Kabsch, 2010) and scaled with SCALA (Evans, 2006) from the CCP4 suite v.6.3.0 (Winn et al., 2011) . Data-collection statistics are reported in Table 1 . Patterson self-rotation calculation was performed with MOLREP (Vagin & Teplyakov, 2010) . Matthews coefficients and electron-density maps were calculated with the programs MATTHEWS_COEF and FFT from the CCP4 suite v.6.3.0, respectively. Heavy-atom substructure determination, positional refinement and phase calculations were performed using the programs autoSHARP (Vonrhein et al., 2007) and SHARP (Bricogne et al., 2003) . Phasing statistics are reported in Table 2 . 
Figure 1
Crystals of native monalysin. 
Results and discussion
Biophysical, functional and preliminary electron-microscopy studies of monalysin have been carried out previously (Opota et al., 2011) . In order to further characterize this novel PFT, we decided to solve its atomic structure by X-ray crystallography. After crystallization optimization, we obtained reproducible crystals (Fig. 1 ) that grew in a few days. Owing to anisotropic diffraction, about 100 crystals were tested and the best diffracted to 2.85 Å resolution. The Patterson selfrotation map shows the presence of ninefold noncrystallographic symmetry (NCS). The Matthews coefficient calculated with nine molecules is 2.64 Å 3 Da À1 (which corresponds to an estimated solvent content of 53.5%), indicating that nine monalysin monomers are present in the asymmetric unit (Matthews, 1968;  Fig. 2 ). However, a previous multi-angle light-scattering analysis revealed that monalysin is composed of 18 monomers in solution. Therefore, it is highly likely that the content of the asymmetric unit is one half of the monalysin oligomer.
Monalysin presents no sequence homology to any protein of known structure. Therefore, it was necessary to solve the phase problem by means of multiple isomorphous replacement or multiplewavelength anomalous dispersion methods. In a first attempt, selenomethionine-substituted monalysin crystals were obtained and a data set was collected only at the selenium peak wavelength owing to radiation damage. However, no selenium site could be identified. In another approach, more than 60 native monalysin crystals were soaked in various heavy-atom derivatives and were tested on beamlines ID29 and ID23 at the ESRF and on the PROXIMA1 beamline at the SOLEIL synchrotron. Of the 22 data sets collected (only at the heavy-atom peak wavelength owing to radiation damage), the Ta 6 Br 14 cluster derivative data set gave satisfying results and was used to obtain phases using the single-wavelength anomalous dispersion (SAD) method. An initial substructure of three Ta 6 Br 14 clusters was determined by autoSHARP and SHARP. On the basis of the Patterson self-rotation analysis, we speculated that the asymmetric unit might contain a heavy-atom substructure with ninefold NCS (Fig. 2) . Thus, the positions of the three Ta 6 Br 14 clusters were used to approximately locate the ninefold axis, and the positions of the six putative remaining clusters were deduced by applying a 40 rotation around this axis using the program TURBO-FRODO (Roussel & Cambillau, 1991 ). Positional refinement of the nine Ta 6 Br 14 clusters and phase calculation were then performed with SHARP. Analysis of the resulting anomalous difference Fourier map confirmed the ninefold NCS of the Ta 6 Br 14 cluster substructure in the asymmetric unit (Fig. 3) . The next step will be to improve the phases through solvent flattening, histogram matching and NCS averaging.
